source
- Roche signs $100 million upfront deal with Alector to advance Parkinson's researchRoche announced a partnership with biotech Alector focused on neuroscience and Parkinson's disease, providing an upfront cash payment of $100 million. The agreement aims to combine Roche's resourc…
- Nobel prize honors scientists who pioneered light-activated gene therapy technologyThree researchers received this year’s Nobel Prize in medicine for creating optogenetics, a technique that uses light to steer nerve activity. The award recognizes their foundational work that has…